ARS Pharmaceuticals
Latest round
- Series D
Last raised
- Aug 2021
Total raised
- $75M
Investors
- 2
About ARS Pharmaceuticals
Based in California, US, and founded in 2015 by Richard Lowenthal and Sarina Tanimoto, ARS Pharmaceuticals, Inc. operates as a pharmaceutical company that specializes in the development of drugs for allergy treatment. In April 2023, Araris Biotech AG, a portfolio company of 4BIO Capital Partners, BB Pureos Bioventures, etc acquired ARS Pharmaceutical’s Nectin-4 Antibody from ARS Pharmaceuticals, Inc., a portfolio company of Fidelity Investments, OrbiMed Advisors, Nantahala Capital Management, Nextech and RA Capital, agreed to merge into ARS Pharmaceuticals, Inc. and will continue to operate under the name ARS Pharmaceuticals, Inc, which will trade on the Nasdaq Capital Market under the SPRY ticker. ARS Pharmaceuticals is a biopharmaceutical firm with a primary focus on developing a potentially first-of-its-kind product called neffy (previously known as ARS-1), which can be used for the emergency treatment of Type I allergic reactions such as anaphylaxis. neffy is a combination of epinephrine and intravail, an absorption enhancer that enables it to be administered as a reliable and rapidly absorbed nasal spray with injection-like effectiveness, in a small, portable, and user-friendly form.
Who invested in ARS Pharmaceuticals
2 investors across 2 rounds
See all investors in ARS Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ARS Pharmaceuticals
Who invested in ARS Pharmaceuticals?
ARS Pharmaceuticals has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ARS Pharmaceuticals raised?
ARS Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ARS Pharmaceuticals last raise money?
ARS Pharmaceuticals's most recent round on record is a Series D, in Aug 2021.
What does ARS Pharmaceuticals do?
Based in California, US, and founded in 2015 by Richard Lowenthal and Sarina Tanimoto, ARS Pharmaceuticals, Inc.
Where is ARS Pharmaceuticals headquartered?
ARS Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like ARS Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ARS Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like ARS Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.